allogeneic bone marrow-derived mesenchymal stromal cells (University of Illinois at Chicago/United States Department of Defense)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameallogeneic bone marrow-derived mesenchymal stromal cells (University of Illinois at Chicago/United States Department of Defense)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCorneal DiseasesCorneal Ulcer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois At Chicago
China Registration ClassN/A

Develop Information

Active CompaniesUS Department of DefenseUniversity Of Illinois At Chicago
Inactive CompaniesN/A
Active IndicationsCorneal DiseasesCorneal Ulcer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A